A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life. (Q53992996)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

quality of life

1 reference

based on heuristic

inferred from title

author name string

C Dahlöf

1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

J Bouchard

2

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

P Cortelli

3

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

J Heywood

4

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

J P Jansen

5

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

S Pham

6

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

J Hirsch

7

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

J Adams

8

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

D W Miller

9

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

publication date

1 January 1997

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

11 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

24-34

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

Quality of life assessment among migraine patients treated with sumatriptan

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational investigation of the impact of subcutaneous sumatriptan. III: Workplace productivity and non-workplace activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of health-related quality of life in migraine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational investigation of the impact of subcutaneous sumatriptan. I: Design, methods and clinical findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Acute Migraine With Subcutaneous Sumatriptan

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sumatriptan injection is superior to placebo in the acute treatment of migraine--with regard to both efficacy and general well-being

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The economic cost of migraine. Present state of knowledge

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multinational investigation of the impact of subcutaneous sumatriptan. IV: Patient satisfaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health‐Related Quality of Life in Headache Research

1 reference

https://pubmed.ncbi.nlm.nih.gov/10168040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199700111-00005

0 references

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/10168040

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53992996&oldid=2212340380"